Critical Review: Nexeon Medsystems (OTCMKTS:NXNN) vs. QT Imaging (NASDAQ:QTI)

Nexeon Medsystems (OTCMKTS:NXNN) and QT Imaging (NASDAQ:QTI) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Nexeon Medsystems and QT Imaging, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nexeon Medsystems	0	0	0	0	0.00
QT Imaging	2	0	1	0	1.67

Given Nexeon Medsystems’ higher probable upside, equities research analysts plainly believe Nexeon Medsystems is more favorable than QT Imaging.

Volatility and Risk

Nexeon Medsystems has a beta of 6.98, indicating that its stock price is 598% more volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.11, indicating that its stock price is 111% less volatile than the S&P 500.

Valuation and Earnings

This table compares Nexeon Medsystems and QT Imaging”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nexeon Medsystems	N/A	N/A	N/A	N/A	N/A
QT Imaging	$18.92 million	3.77	-$21.08 million	($2.19)	-2.74

Nexeon Medsystems has higher earnings, but lower revenue than QT Imaging.

Profitability

This table compares Nexeon Medsystems and QT Imaging’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nexeon Medsystems	N/A	N/A	N/A
QT Imaging	-111.40%	N/A	-144.16%

Insider & Institutional Ownership

24.2% of QT Imaging shares are held by institutional investors. 61.2% of Nexeon Medsystems shares are held by company insiders. Comparatively, 28.8% of QT Imaging shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Nexeon Medsystems beats QT Imaging on 5 of the 9 factors compared between the two stocks.

About Nexeon Medsystems

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.

About QT Imaging

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.